We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hybrid vigor.
- Authors
Williams, Keith
- Abstract
This article focuses on the significance of setting up a hybrid company in an emerging biotechnology space. The reason that Proteome Systems have set up a hybrid business is that they find the tools side of the business is intricately enmeshed with drug discovery business. When Proteome Systems was set up, proteomics was in an embryonic state. Proteome plans to take a significant position in the drug discovery area but on reviewing pharmaceutical companies, it found that they invariably did not invest sufficiently in innovation; instead, they ended up relying on existing technology. People should realize that discovery and technology are intimately tied up, each cross-fertilizing the other. In the longer term, it may make sense to separate the businesses, but for the foreseeable future, having them together is very powerful.
- Subjects
PROTEOME Systems Ltd.; PHARMACEUTICAL industry; DRUG development; BIOTECHNOLOGY
- Publication
Nature Biotechnology, 2003, Vol 21, Issue 8, p843
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0803-843a